,130 Collectively, the KRT17P3/miR-497-5p/mTOR regulatory axis affects the chemosensitivity of NSCLC, indicating that this axis represents a promising curative target for NSCLC patients who have developed resistance to cisplatin. This evidence concerns the gene MTOR and non-small cell lung carcinoma.